LLY vs PTCT
As of Sep 20, 2026, ELI LILLY (LLY) scores 7.2/10 and PTC Therapeutics (PTCT) 3.4/10 on AlphaStocks' five-model composite, so LLY scores higher. LLY trades 76% above its model fair value.
LLY
ELI LILLY & Co
7.2
Consider Buy
$1,152.46
PTCT
PTC THERAPEUTICS, INC.
3.4
Weak
$65.41
LLY vs PTCT: Which is the Better Investment?
ELI LILLY & Co (LLY) scores 7.2/10 while PTC THERAPEUTICS, INC. (PTCT) scores 3.4/10 on AlphaStocks' composite model. ELI LILLY & Co has the higher composite rating of Consider Buy. On a P/E basis, PTC THERAPEUTICS, INC. trades at 8.5x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | LLY | PTCT |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 7.2/10▲ | 3.4/10 |
| Rating | Consider Buy▲ | Weak |
| Price | $1,152.46 | $65.41 |
| P/E Ratio | 50.2 | 8.5▲ |
| ROE | 82.0%▲ | -23.6% |
| Market Cap | $1.0T | $5B |
| Fair Value | $656.48 | — |
| Dividend Yield | 0.5% | — |
| Sector Rank | #11 of 168▲ | #152 of 168 |
| Model Verdicts | ||
| Piotroski | Strong▲ | Neutral |
| Buffett | Strong▲ | Caution |
| Graham | Caution | Neutral▲ |
| Lynch | Neutral▲ | Limited Data |
| Greenblatt | Caution | Caution |
Related comparisons
LLY vs PTCT: Which Stock Scores Higher?
ELI LILLY & Co (LLY) and PTC THERAPEUTICS, INC. (PTCT) are both in the Health Care sector. LLY currently leads with a composite score of 7.2/10 (Consider Buy) compared to PTCT's 3.4/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer